JMB

Cited by CrossRef (11)

  1. Corneliu Ovidiu Vrancianu, Irina Gheorghe, Ilda Barbu Czobor, Mariana Carmen Chifiriuc. Antibiotic Resistance Profiles, Molecular Mechanisms and Innovative Treatment Strategies of Acinetobacter baumannii. Microorganisms 2020;8:935
    https://doi.org/10.3390/microorganisms8060935
  2. Masego Mmatli, Nontombi Marylucy Mbelle, John Osei Sekyere. Global epidemiology, genetic environment, risk factors and therapeutic prospects of mcr genes: A current and emerging update. Front. Cell. Infect. Microbiol. 2022;12
    https://doi.org/10.3389/fcimb.2022.941358
  3. Bo Zhang, Hongdan Wang, Weiwei Zhao, Chunlan Shan, Chaoying Liu, Libo Gao, Ru Zhao, Pingxing Ao, Peng Xiao, Longbao Lv, Hong Gao. New insights into the construction of wild-type Saba pig-derived Escherichia coli irp2 gene deletion strains. 3 Biotech 2021;11
    https://doi.org/10.1007/s13205-021-02951-0
  4. Ali A. Rabaan, Mona A. Al Fares, Manar Almaghaslah, Tariq Alpakistany, Nawal A. Al Kaabi, Saleh A. Alshamrani, Ahmad A. Alshehri, Ibrahim Abdullah Almazni, Ahmed Saif, Abdulrahim R. Hakami, Faryal Khamis, Mubarak Alfaresi, Zainab Alsalem, Zainab A. Alsoliabi, Kawthar Amur Salim Al Amri, Amal K. Hassoueh, Ranjan K. Mohapatra, Kovy Arteaga-Livias, Mohammed Alissa. Application of CRISPR-Cas System to Mitigate Superbug Infections. Microorganisms 2023;11:2404
    https://doi.org/10.3390/microorganisms11102404
  5. Manuel González de Aledo, Mónica González-Bardanca, Lucía Blasco, Olga Pacios, Inés Bleriot, Laura Fernández-García, Melisa Fernández-Quejo, María López, Germán Bou, María Tomás. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies. Antibiotics 2021;10:756
    https://doi.org/10.3390/antibiotics10070756
  6. Khushal Khambhati, Gargi Bhattacharjee, Nisarg Gohil, Gurneet K. Dhanoa, Antonia P. Sagona, Indra Mani, Nhat Le Bui, Dinh‐Toi Chu, Janardhan Keshav Karapurkar, Su Hwa Jang, Hee Yong Chung, Rupesh Maurya, Khalid J. Alzahrani, Suresh Ramakrishna, Vijai Singh. Phage engineering and phage‐assisted CRISPR‐Cas delivery to combat multidrug‐resistant pathogens. Bioengineering & Transla Med 2023;8
    https://doi.org/10.1002/btm2.10381
  7. Corneliu Ovidiu Vrancianu, Laura Ioana Popa, Coralia Bleotu, Mariana Carmen Chifiriuc. Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance. Front. Microbiol. 2020;11
    https://doi.org/10.3389/fmicb.2020.00761
  8. Mouna Hamel, Jean-Marc Rolain, Sophie Alexandra Baron. The History of Colistin Resistance Mechanisms in Bacteria: Progress and Challenges. Microorganisms 2021;9:442
    https://doi.org/10.3390/microorganisms9020442
  9. Amani H. Al-Fadhli, Wafaa Yousef Jamal. Recent advances in gene-editing approaches for tackling antibiotic resistance threats: a review. Front. Cell. Infect. Microbiol. 2024;14
    https://doi.org/10.3389/fcimb.2024.1410115
  10. Shuo Liu, Meng‐Ze Du, Qing‐Feng Wen, Juanjuan Kang, Chuan Dong, Lifeng Xiong, Jian Huang, Feng‐Biao Guo. Comprehensive exploration of the enzymes catalysing oxygen‐involved reactions and COGs relevant to bacterial oxygen utilization. Environmental Microbiology 2018;20:3836
    https://doi.org/10.1111/1462-2920.14399
  11. Subhasree Roy, Sharmi Naha, Ankur Rao, Sulagna Basu. Advances in CRISPR/Cas and Related Technologies. 2018.
    https://doi.org/10.1016/bs.pmbts.2020.12.005

© 2009. The Korean Society for Microbiology and Biotechnology. / Powered by INFOrang Co., Ltd